Eric Gauthier

4.9k citations
42 papers · 3.1k · 4 hit papers · h-index 17

Impact in

  • Oncology top 1%
    • Cancer-related Molecular Pathways
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Vascular Tumors and Angiosarcomas
    • Advanced Breast Cancer Therapies

Papers in

    • Advanced Breast Cancer Therapies 31
    • Cancer-related Molecular Pathways 11
    • HER2/EGFR in Cancer Research 8
    • Cancer Treatment and Pharmacology 6
    • PARP inhibition in cancer therapy 5

Eric Gauthier

37 papers receiving 3.1k citations

Eric Gauthier's Hit Papers

Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer 2024 · 81 citations
810+3+6Years since publication50010001.5k

Peers

Eric Gauthier
Comparison fields: 5 of 87
  • Oncology 2.4k
  • Pulmonary and Respiratory Medicine 2.6k
  • Cancer Research 928
  • Genetics 650
  • Cardiology and Cardiovascular Medicine 176
Replace Martin Frenzel with:
Martin Frenzel United States
Meritxell Bellet Spain
Kathy Puyana Theall United States
S. Phan United States
Eva Ciruelos Spain
Scott Cruickshank United States
Paul Frewer United Kingdom
Gábor Rubovszky Hungary
Edda Simoncini Italy
Giancarlo Bisagni Italy
Eric Gauthier relative to Martin Frenzel United States Martin Frenzel's profile →
Citations per field
00.5×3.7×
Martin Frenzel · 1×
Citations per year

Countries citing papers authored by Eric Gauthier

Since Specialization
Citations

This map shows the geographic impact of Eric Gauthier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Gauthier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Gauthier more than expected).

Fields of papers citing papers by Eric Gauthier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Gauthier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Gauthier. The network helps show where Eric Gauthier may publish in the future.

Co-authors

The 25 scholars most cited alongside Eric Gauthier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric Gauthier Line = papers co-authored together Eric Gauthier links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Palbociclib and Letrozole in Advanced Breast Cancer
Hit paper breakdown →
20161873
2
Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up
Hit paper breakdown →
2019286
3 2012148
4
Overall survival (OS) with first-line palbociclib plus letrozole (PAL+LET) versus placebo plus letrozole (PBO+LET) in women with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer (ER+/HER2− ABC): Analyses from PALOMA-2.
Hit paper breakdown →
2022109
5 201386
6
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer
Hit paper breakdown →
202481
7 201681
8 201867
9 201961
10 201955
11 201955
12 202140
13 201833
14 202025
15 198624
16 201921
17 201817
18 201711
19 200910
20 20058

About Eric Gauthier

Eric Gauthier is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Genetics and Genetics, having authored 42 papers that have together received 3.1k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (31 papers), Cancer-related Molecular Pathways (11 papers), HER2/EGFR in Cancer Research (8 papers), Cancer Treatment and Pharmacology (6 papers), PARP inhibition in cancer therapy (5 papers), BRCA gene mutations in cancer (5 papers), Breast Cancer Treatment Studies (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Oncology (2.4k citations), Pulmonary and Respiratory Medicine (2.6k citations), Cancer Research (928 citations), Genetics (650 citations) and Cardiology and Cardiovascular Medicine (176 citations). Eric Gauthier has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Hope S. Rugo, Dongrui R. Lu, Richard S. Finn, Karen A. Gelmon, Véronique Dièras, Dennis J. Slamon, Nadia Harbeck, Oleg Lipatov, Miguel Martín and Seock‐Ah Im. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, The Oncologist, Annals of Oncology and ESMO Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact